ArticleMolecular biology reports2026
MTA does not induce oxidative stress and apoptotic response, or calcium-related cellular stress and preserves extracellular matrix homeostasis.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to investigate the time-dependent biological effects of mineral trioxide aggregate (MTA) on cellular viability and the gene expressions associated with oxidative stress response (Nrf2), apoptosis-related signaling (p53), calcium homeostasis (CALB1), and extracellular matrix regulation (FN) in L-929 fibroblasts. METHODS AND
resultsMTA specimens were allowed to set for 4, 6, 8, and 24 h. Eluates were obtained according to ISO-10993-12 guidelines and applied to cells. Cell viability was assessed by MTT assay. Relative mRNA expressions of Nrf2, p53, CALB1, and FN were analyzed by real-time PCR. One-way ANOVA and post-hoc Tukey's were used. Higher cell viability than the positive control was obtained. Viability remained above the 70% biocompatibility threshold in all time periods. A time-dependent fluctuation in viability was observed, with differences between 4 h and 6 h and between 4 h and 8 h (p < 0.05). No significant differences were detected in Nrf2, p53, CALB1, or FN expression levels between the negative control and MTA-treated groups at any time point (p > 0.05).
conclusionMTA preserved cellular viability and molecular homeostasis without inducing oxidative, apoptotic, or calcium-related imbalance. The inclusion of Nrf2 and CALB1 as previously unexplored parameters provides additional mechanistic insight into the biocompatibility profile of MTA. MTA maintained cellular homeostasis throughout its critical setting phase without activating oxidative stress, apoptosis-related signaling, or calcium imbalance pathways. The stable expression of Nrf2, p53, and CALB1 suggests that the favorable clinical performance may depend not only on biocompatibility but also on its ability to preserve intracellular equilibrium during early tissue contact.
Indexed as
Identifiers
42496770What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.